Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
BARICITINIB
(2018)
Small molecule
Tyrosine-protein kinase JAK1 inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Immune System Diseases
BARICITINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
ISP4442I3Y
Molecule Type:
Small molecule
Molecular Formula:
C16H17N7O2S
Molecular Weight:
371.43
AlogP:
1.1
PSA:
120.56
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RIFAMYCIN SODIUM
(2018)
Small molecule
DNA-directed RNA polymerase inhibitor
Unknown
Approved
Diarrhea
RIFAMYCIN SODIUM
×
Maximum Phase:
4
First Approval:
2018
UNII:
32086GS35Z
Molecule Type:
Small molecule
Molecular Formula:
C37H46NNaO12
Molecular Weight:
719.76
AlogP:
4.75
PSA:
201.31
HBD:
6.0
HBA:
#RotB:
2.0
Source:
PLAZOMICIN
(2018)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
PLAZOMICIN
×
Maximum Phase:
4
First Approval:
2018
UNII:
LYO9XZ250J
Molecule Type:
Small molecule
Molecular Formula:
C25H48N6O10
Molecular Weight:
592.69
AlogP:
-5.36
PSA:
269.29
HBD:
11.0
HBA:
#RotB:
13.0
Source:
ERAVACYCLINE DIHYDROCHLORIDE
(2018)
Small molecule
Bacterial 70S ribosome inhibitor
INTRAVENOUS
Approved
Intraabdominal Infections
ERAVACYCLINE DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
WK1NMH89VJ
Molecule Type:
Small molecule
Molecular Formula:
C27H33Cl2FN4O8
Molecular Weight:
631.49
AlogP:
0.29
PSA:
193.73
HBD:
6.0
HBA:
#RotB:
5.0
Source:
LORLATINIB
(2018)
Small molecule
ALK tyrosine kinase receptor inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung; Lymphoma; Neoplasms
LORLATINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
OSP71S83EU
Molecule Type:
Small molecule
Molecular Formula:
C21H19FN6O2
Molecular Weight:
406.42
AlogP:
2.8
PSA:
110.06
HBD:
1.0
HBA:
#RotB:
0.0
Source:
LOFEXIDINE HYDROCHLORIDE
(2018)
Small molecule
Adrenergic receptor alpha-2 agonist
ORAL
Approved
Substance Withdrawal Syndrome
LOFEXIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
V47G1SDI1B
Molecule Type:
Small molecule
Molecular Formula:
C11H13Cl3N2O
Molecular Weight:
295.6
AlogP:
2.76
PSA:
33.62
HBD:
1.0
HBA:
#RotB:
3.0
Source:
OMADACYCLINE TOSYLATE
(2018)
Small molecule
Bacterial 70S ribosome inhibitor
INTRAVENOUS; ORAL
Approved
Pneumonia, Bacterial; Skin Diseases, Bacterial
OMADACYCLINE TOSYLATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
5658Y89YCD
Molecule Type:
Small molecule
Molecular Formula:
C36H48N4O10S
Molecular Weight:
728.87
AlogP:
1.32
PSA:
176.66
HBD:
6.0
HBA:
#RotB:
6.0
Source:
OMADACYCLINE
(2018)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
OMADACYCLINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
090IP5RV8F
Molecule Type:
Small molecule
Molecular Formula:
C29H40N4O7
Molecular Weight:
556.66
AlogP:
1.32
PSA:
176.66
HBD:
6.0
HBA:
#RotB:
6.0
Source:
SARECYCLINE
(2018)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
SARECYCLINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
94O110CX2E
Molecule Type:
Small molecule
Molecular Formula:
C24H29N3O8
Molecular Weight:
487.51
AlogP:
0.11
PSA:
173.86
HBD:
5.0
HBA:
#RotB:
5.0
Source:
TALAZOPARIB
(2018)
Small molecule
Poly [ADP-ribose] polymerase 2 inhibitor
Unknown
Approved
Neoplasms
TALAZOPARIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
9QHX048FRV
Molecule Type:
Small molecule
Molecular Formula:
C19H14F2N6O
Molecular Weight:
380.36
AlogP:
2.63
PSA:
88.49
HBD:
2.0
HBA:
#RotB:
2.0
Source:
MIGALASTAT
(2018)
Small molecule
Alpha-galactosidase A stabiliser
Unknown
Approved
Unknown
MIGALASTAT
×
Maximum Phase:
4
First Approval:
2018
UNII:
C4XNY919FW
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO4
Molecular Weight:
163.17
AlogP:
-2.97
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
1.0
Source:
E133
(2019)
Small molecule
Unknown
Unknown
Approved
Unknown
E133
×
Maximum Phase:
3
First Approval:
2019
UNII:
H3R47K3TBD
Molecule Type:
Small molecule
Molecular Formula:
C47H49N3O7S2
Molecular Weight:
832.06
AlogP:
9.31
PSA:
139.08
HBD:
2.0
HBA:
#RotB:
15.0
Source:
ESKETAMINE
(2019)
Small molecule
Glutamate [NMDA] receptor negative allosteric modulator
Unknown
Approved
Depressive Disorder
ESKETAMINE
×
Maximum Phase:
4
First Approval:
2019
UNII:
50LFG02TXD
Molecule Type:
Small molecule
Molecular Formula:
C13H16ClNO
Molecular Weight:
237.73
AlogP:
2.9
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FERRIC MALTOL
(2019)
Small molecule
Supplement
ORAL
Approved
Unknown
FERRIC MALTOL
×
Maximum Phase:
4
First Approval:
2019
UNII:
MA10QYF1Z0
Molecule Type:
Small molecule
Molecular Formula:
C18H15FeO9
Molecular Weight:
431.15
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PITOLISANT HYDROCHLORIDE
(2019)
Small molecule
Histamine H3 receptor inverse agonist
ORAL
Approved
Disorders of Excessive Somnolence; Narcolepsy
PITOLISANT HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2019
UNII:
YV33CH63HI
Molecule Type:
Small molecule
Molecular Formula:
C17H27Cl2NO
Molecular Weight:
332.32
AlogP:
4.17
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
8.0
Source:
TAFAMIDIS
(2019)
Small molecule
Transthyretin stabiliser
ORAL
Approved
Amyloidosis; Amyloidosis, Familial; Cardiomyopathies
TAFAMIDIS
×
Maximum Phase:
4
First Approval:
2019
UNII:
8FG9H9D31J
Molecule Type:
Small molecule
Molecular Formula:
C14H7Cl2NO3
Molecular Weight:
308.12
AlogP:
4.5
PSA:
63.33
HBD:
1.0
HBA:
#RotB:
2.0
Source:
AIR POLYMER-TYPE A
(2019)
Small molecule
Ultrasound contrast agent
Unknown
Approved
Unknown
AIR POLYMER-TYPE A
×
Maximum Phase:
4
First Approval:
2019
UNII:
WLT3PF2KX0
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BRILLIANT BLUE G
(2019)
Small molecule
Membrane staining aid in ophthalmic surgery
Unknown
Approved
Unknown
BRILLIANT BLUE G
×
Maximum Phase:
4
First Approval:
2019
UNII:
M1ZRX790SI
Molecule Type:
Small molecule
Molecular Formula:
C47H48N3NaO7S2
Molecular Weight:
854.04
AlogP:
9.31
PSA:
139.08
HBD:
2.0
HBA:
#RotB:
15.0
Source:
PEXIDARTINIB
(2019)
Small molecule
Macrophage colony stimulating factor receptor inhibitor
Unknown
Approved
Neoplasms
PEXIDARTINIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
6783M2LV5X
Molecule Type:
Small molecule
Molecular Formula:
C20H15ClF3N5
Molecular Weight:
417.82
AlogP:
5.23
PSA:
66.49
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PITOLISANT
(2019)
Small molecule
Histamine H3 receptor inverse agonist
Unknown
Approved
Unknown
PITOLISANT
×
Maximum Phase:
4
First Approval:
2019
UNII:
4BC83L4PIY
Molecule Type:
Small molecule
Molecular Formula:
C17H26ClNO
Molecular Weight:
295.85
AlogP:
4.17
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
8.0
Source:
ZANUBRUTINIB
(2019)
Small molecule
Tyrosine-protein kinase BTK inhibitor
Unknown
Approved
Lymphoma, Mantle-Cell; Neoplasms
ZANUBRUTINIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
AG9MHG098Z
Molecule Type:
Small molecule
Molecular Formula:
C27H29N5O3
Molecular Weight:
471.56
AlogP:
4.22
PSA:
102.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
FLUORODOPA F 18
(2019)
Small molecule
Diagnostic agent
Unknown
Approved
Unknown
FLUORODOPA F 18
×
Maximum Phase:
4
First Approval:
2019
UNII:
2C598205QX
Molecule Type:
Small molecule
Molecular Formula:
C9H10FNO4
Molecular Weight:
214.18
AlogP:
0.19
PSA:
103.78
HBD:
4.0
HBA:
#RotB:
3.0
Source:
ISTRADEFYLLINE
(2019)
Small molecule
Adenosine A2a receptor antagonist
ORAL
Approved
Parkinson Disease
ISTRADEFYLLINE
×
Maximum Phase:
4
First Approval:
2019
UNII:
2GZ0LIK7T4
Molecule Type:
Small molecule
Molecular Formula:
C20H24N4O4
Molecular Weight:
384.44
AlogP:
2.12
PSA:
80.28
HBD:
0.0
HBA:
#RotB:
6.0
Source:
SIPONIMOD FUMARATE
(2019)
Small molecule
Sphingosine 1-phosphate receptor Edg-1 agonist
Unknown
Approved
Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting
SIPONIMOD FUMARATE
×
Maximum Phase:
4
First Approval:
2019
UNII:
Z7G02XZ0M6
Molecule Type:
Small molecule
Molecular Formula:
C62H74F6N4O10
Molecular Weight:
1149.28
AlogP:
6.77
PSA:
62.13
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TAFAMIDIS MEGLUMINE
(2019)
Small molecule
Transthyretin stabiliser
ORAL
Approved
Amyloidosis; Amyloidosis, Familial; Cardiomyopathies
TAFAMIDIS MEGLUMINE
×
Maximum Phase:
4
First Approval:
2019
UNII:
ZU7CF08A1A
Molecule Type:
Small molecule
Molecular Formula:
C21H24Cl2N2O8
Molecular Weight:
503.34
AlogP:
4.5
PSA:
63.33
HBD:
1.0
HBA:
#RotB:
2.0
Source:
DIROXIMEL FUMARATE
(2019)
Small molecule
Kelch-like ECH-associated protein 1 inhibitor
Unknown
Approved
Immune System Diseases; Multiple Sclerosis
DIROXIMEL FUMARATE
×
Maximum Phase:
4
First Approval:
2019
UNII:
K0N0Z40J3W
Molecule Type:
Small molecule
Molecular Formula:
C11H13NO6
Molecular Weight:
255.23
AlogP:
-0.59
PSA:
89.98
HBD:
0.0
HBA:
#RotB:
5.0
Source:
VOXELOTOR
(2019)
Small molecule
Hemoglobin HbA positive modulator
Unknown
Approved
Anemia, Sickle Cell
VOXELOTOR
×
Maximum Phase:
4
First Approval:
2019
UNII:
3ZO554A4Q8
Molecule Type:
Small molecule
Molecular Formula:
C19H19N3O3
Molecular Weight:
337.38
AlogP:
3.62
PSA:
77.24
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PRETOMANID
(2019)
Small molecule
Unknown
ORAL
Approved
Tuberculosis; Tuberculosis, Pulmonary
PRETOMANID
×
Maximum Phase:
4
First Approval:
2019
UNII:
2XOI31YC4N
Molecule Type:
Small molecule
Molecular Formula:
C14H12F3N3O5
Molecular Weight:
359.26
AlogP:
2.67
PSA:
88.65
HBD:
0.0
HBA:
#RotB:
5.0
Source:
SIPONIMOD
(2019)
Small molecule
Sphingosine 1-phosphate receptor Edg-1 agonist
Unknown
Approved
Immune System Diseases
SIPONIMOD
×
Maximum Phase:
4
First Approval:
2019
UNII:
RR6P8L282I
Molecule Type:
Small molecule
Molecular Formula:
C29H35F3N2O3
Molecular Weight:
516.6
AlogP:
6.77
PSA:
62.13
HBD:
1.0
HBA:
#RotB:
9.0
Source:
LEVAMLODIPINE
(2019)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
LEVAMLODIPINE
×
Maximum Phase:
4
First Approval:
2019
UNII:
0P6NLP6806
Molecule Type:
Small molecule
Molecular Formula:
C20H25ClN2O5
Molecular Weight:
408.88
AlogP:
2.27
PSA:
99.88
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TRIFAROTENE
(2019)
Small molecule
Retinoic acid receptor gamma agonist
TOPICAL
Approved
Acne Vulgaris
TRIFAROTENE
×
Maximum Phase:
4
First Approval:
2019
UNII:
0J8RN2W0HK
Molecule Type:
Small molecule
Molecular Formula:
C29H33NO4
Molecular Weight:
459.59
AlogP:
5.99
PSA:
70.0
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ALPELISIB
(2019)
Small molecule
PI3-kinase p110-alpha subunit inhibitor
ORAL
Approved
Breast Neoplasms; Neoplasms
ALPELISIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
08W5N2C97Q
Molecule Type:
Small molecule
Molecular Formula:
C19H22F3N5O2S
Molecular Weight:
441.48
AlogP:
3.84
PSA:
101.21
HBD:
2.0
HBA:
#RotB:
4.0
Source:
CEFIDEROCOL SULFATE TOSYLATE
(2019)
Small molecule
Bacterial penicillin-binding protein inhibitor
Unknown
Approved
Pneumonia, Bacterial; Urinary Tract Infections
CEFIDEROCOL SULFATE TOSYLATE
×
Maximum Phase:
4
First Approval:
2019
UNII:
TTP8LBP45D
Molecule Type:
Small molecule
Molecular Formula:
C118H138Cl3N21O47S11
Molecular Weight:
3061.6
AlogP:
-0.18
PSA:
256.9
HBD:
6.0
HBA:
#RotB:
13.0
Source:
LEFAMULIN ACETATE
(2019)
Small molecule
Bacterial 70S ribosome inhibitor
INTRAVENOUS; ORAL
Approved
Pneumonia, Bacterial
LEFAMULIN ACETATE
×
Maximum Phase:
4
First Approval:
2019
UNII:
HDN0B924X4
Molecule Type:
Small molecule
Molecular Formula:
C30H49NO7S
Molecular Weight:
567.79
AlogP:
3.87
PSA:
109.85
HBD:
3.0
HBA:
#RotB:
5.0
Source:
ESKETAMINE HYDROCHLORIDE
(2019)
Small molecule
Glutamate [NMDA] receptor negative allosteric modulator
NASAL
Approved
Depressive Disorder, Major
ESKETAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2019
UNII:
L8P1H35P2Z
Molecule Type:
Small molecule
Molecular Formula:
C13H17Cl2NO
Molecular Weight:
274.19
AlogP:
2.9
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ERDAFITINIB
(2019)
Small molecule
Fibroblast growth factor receptor inhibitor
ORAL
Approved
Carcinoma, Transitional Cell; Neoplasms; Urinary Bladder Neoplasms
ERDAFITINIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
890E37NHMV
Molecule Type:
Small molecule
Molecular Formula:
C25H30N6O2
Molecular Weight:
446.56
AlogP:
4.18
PSA:
77.33
HBD:
1.0
HBA:
#RotB:
9.0
Source:
1
2
…
69
70
71
72
73
74
75
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA